FDA Inspection 1192638 — CSL Plasma Inc.
The FDA completed an inspection of CSL Plasma Inc. on Nov 3, 2022 in Wilmington, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 3, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Wilmington, NC (United States)